Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about NVO

Recent news which mentions NVO

...

16 17 18 19 20 21 22 23 24

...

Hims & Hers Stock Dropped: Here's What You Need to Know

October 24, 2024

Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'

October 23, 2024

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

October 23, 2024

Novo Nordisk's Death Cross: Is A Turnaround Coming For The Ozempic, Wegovy Maker?

October 23, 2024

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

October 22, 2024

Wegovy Maker Novo Nordisk's Oral Diabetes Pill Cuts Heart Attacks, Stroke Events By 14%

October 21, 2024

After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent

October 18, 2024

Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug

October 18, 2024

Behind the Scenes of Novo Nordisk's Latest Options Trends

October 17, 2024

Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows

October 17, 2024

'Miracle' Weight Loss Drug Ozempic And Similar Drugs Reduce Alcohol And Opioid Overdose, Study Reveals

October 17, 2024

Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years

October 16, 2024

Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?

October 16, 2024

Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival

October 15, 2024

Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?

October 14, 2024

3 No-Brainer Growth Stocks to Buy in October

October 13, 2024

Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names

October 11, 2024

Criminal Networks Cash In On Demand For Weight Loss Drugs, Authorities Say

October 11, 2024

Analyst Ratings For Novo Nordisk

October 10, 2024

FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears

October 10, 2024

Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves

October 10, 2024

2 No-Brainer Dividend Growth Stocks to Buy Right Now

October 10, 2024

A Closer Look at Novo Nordisk's Options Market Dynamics

October 09, 2024

Got $5,000? These 3 Growth Stocks Are on Sale Right Now.

October 09, 2024

What's Going With WeightWatchers Stock On Wednesday?

October 09, 2024

Prediction: 3 of Wall Street's Most Influential Stocks Can Plunge if Kamala Harris Wins in November

October 08, 2024

Billion-Dollar News for Eli Lilly Stock Investors

October 07, 2024

Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs

October 07, 2024

Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?

October 06, 2024

Prediction: These 2 Stocks Will Join Nvidia, Meta, Apple, Amazon, and Microsoft in the Trillion-Dollar Club by 2030

October 06, 2024

...

16 17 18 19 20 21 22 23 24

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.